See more : Thai Agro Energy Public Company Limited (TAE.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Kolon Life Science Inc. (102940.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kolon Life Science Inc., a leading company in the industry within the sector.
You may be interested
- Parabellum Resources Limited (PBL.AX) Income Statement Analysis – Financial Results
- SmartCentres Real Estate Investment Trust (SRU-UN.TO) Income Statement Analysis – Financial Results
- Duxton Farms Limited (DBF.AX) Income Statement Analysis – Financial Results
- Plant Health Care plc (PLHCF) Income Statement Analysis – Financial Results
- Greenstone Resources Limited (GSR.AX) Income Statement Analysis – Financial Results
Kolon Life Science Inc. (102940.KQ)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 124.64B | 161.58B | 165.49B | 129.41B | 148.54B |
| Cost of Revenue | 112.23B | 124.45B | 128.28B | 110.52B | 123.18B |
| Gross Profit | 12.41B | 37.14B | 37.20B | 18.90B | 25.36B |
| Gross Profit Ratio | 9.96% | 22.98% | 22.48% | 14.60% | 17.07% |
| Research & Development | 14.89B | 13.58B | 14.33B | 13.15B | 18.49B |
| General & Administrative | 8.31B | 8.46B | 6.85B | 13.36B | 10.01B |
| Selling & Marketing | 3.15B | 3.30B | 3.75B | 4.27B | 4.76B |
| SG&A | 11.46B | 11.76B | 10.61B | 17.63B | 30.45B |
| Other Expenses | 10.15B | 8.09B | 2.01B | 2.51B | 0.00 |
| Operating Expenses | 36.51B | 26.90B | 28.98B | 58.33B | 102.28B |
| Cost & Expenses | 148.73B | 151.35B | 157.26B | 168.85B | 225.46B |
| Interest Income | 168.59M | 114.07M | 120.40M | 135.40M | 460.20M |
| Interest Expense | 5.86B | 3.72B | 6.01B | 5.52B | 3.74B |
| Depreciation & Amortization | 8.83B | 9.47B | 11.30B | 13.03B | 14.04B |
| EBITDA | -18.91B | 12.11B | 15.55B | -24.65B | -12.50B |
| EBITDA Ratio | -15.17% | 12.48% | 10.60% | -21.28% | -8.42% |
| Operating Income | -24.10B | 2.64B | 3.87B | -25.84B | -26.54B |
| Operating Income Ratio | -19.33% | 1.63% | 2.34% | -19.96% | -17.87% |
| Total Other Income/Expenses | -9.50B | 1.48B | -7.88B | -17.36B | -53.65B |
| Income Before Tax | -33.60B | 4.12B | -4.01B | -43.20B | -80.20B |
| Income Before Tax Ratio | -26.96% | 2.55% | -2.42% | -33.38% | -53.99% |
| Income Tax Expense | 1.25M | 107.93M | -2.64B | -14.74B | 12.13B |
| Net Income | -30.73B | 2.13B | -1.37B | -43.20B | -92.32B |
| Net Income Ratio | -24.65% | 1.32% | -0.83% | -33.38% | -62.15% |
| EPS | -2.69K | 187.00 | -121.00 | -3.79K | -8.10K |
| EPS Diluted | -2.43K | 163.00 | -121.00 | -3.79K | -8.10K |
| Weighted Avg Shares Out | 11.41M | 11.41M | 11.36M | 11.40M | 11.40M |
| Weighted Avg Shares Out (Dil) | 12.64M | 13.09M | 11.36M | 11.40M | 11.40M |
No news found for: 102940.KQ
Source: https://incomestatements.info
Category: Stock Reports